# CJC-1295 / GHRP-2 Blend

> This blend pairs CJC-1295 with GHRP-2, positioned as a middle ground between the CJC-1295/ipamorelin pairing (more selective, milder) and CJC-1295/GHRP-6 pairing (stronger appetite stimulation). GHRP-2 is a more potent secretagogue than ipamorelin at the ghrelin receptor while producing less appetite stimulation than GHRP-6. Both components have an extensive individual research history in growth-hormone secretagogue literature, though the fixed combination has not been studied as its own entity. It is discussed in the context of sustained GH elevation for recovery and body-composition-focused research. It is not approved for human medical use.

- URL: https://www.lifeconverted.com/peptides/cjc1295-ghrp2-blend
- Primary category: GH Blends
- Effectiveness rank: #999 in Growth Hormone Peptides; #999 in GH Releasing Hormones; #6 in GH Blends
- Evidence level: Well studied
- Route: Subcutaneous (Injected subcutaneously into the abdomen; dosing frequency depends on whether the non-DAC or DAC form of CJC-1295 is used.)
- Dose range: 200-500 mcg
- Dose tiers: low 200 mcg; moderate 300 mcg; high 500 mcg
- Half-life: CJC-1295 without DAC is reported at roughly 30 minutes (or several days with DAC); GHRP-2 is reported at roughly 30-60 minutes.
- Timing: ~30 min before bed, empty stomach
- Cycle: 8-12 weeks on, 4 weeks off (Cycling recommendations mirror those for other CJC-1295-based pairings, aimed at reducing theoretical pituitary downregulation.)
- Storage: Refrigerate after reconstitution (2-8°C); commonly described as stable for 3-4 weeks.

## Mechanism of action

CJC-1295 sustains elevated GHRH-receptor stimulation, particularly in its DAC-extended form, supporting a longer window of GH release. GHRP-2 provides a potent ghrelin-receptor-driven GH pulse with a moderate side-effect profile relative to other GHRPs. Combined, the two are described as producing strong, sustained GH release across the dosing window.

## Reported benefits

- Sustains elevated growth-hormone levels
- Supports recovery
- Associated with lean mass support in research contexts
- Moderate appetite effect compared with GHRP-6 pairings

## Reported side effects

- Water retention
- Injection site irritation
- Mild appetite increase
- Headache
- Flushing

## Common protocols

- GH Optimization
- Muscle Growth

## Stacking notes

Positioned as an alternative to CJC-1295/ipamorelin for researchers interested in a more potent secretagogue, at the cost of a somewhat less selective side-effect profile.

---

Educational information only, not medical advice. Full disclaimer: https://www.lifeconverted.com/disclaimer